Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Duloxetine Tapering Guidelines

  • For patients who have been on duloxetine long-term (≥1 year), tapers of 10% per month or slower are likely to be better tolerated than more rapid tapers, as recommended by the MMWR Recommendations and Reports 1
  • As the taper progresses to very low doses, extend the interval between doses (e.g., every other day, then every third day) before complete discontinuation, following the guidelines from MMWR Recommendations and Reports 1

Managing Withdrawal Symptoms

  • Follow up frequently (at least monthly) with patients during the tapering process, as suggested by MMWR Recommendations and Reports 1
  • If withdrawal symptoms become severe, return to the previous well-tolerated dose and slow the taper further, according to MMWR Recommendations and Reports 1
  • Use adjunctive medications to manage specific withdrawal symptoms if they occur, such as α2-adrenergic agonists like clonidine for increased sympathetic activity, as recommended by the Mayo Clinic Proceedings 2
  • For insomnia, consider short-term use of non-benzodiazepine sleep aids, as suggested by the Mayo Clinic Proceedings 2
  • For muscle aches, use acetaminophen or NSAIDs, as recommended by the Mayo Clinic Proceedings 2

Special Considerations

  • Clinicians should advise patients of an increased risk for adverse effects if they abruptly return to a previously prescribed higher dose, as noted by MMWR Recommendations and Reports 1
  • At times, tapers might need to be paused and restarted when the patient is ready, according to MMWR Recommendations and Reports 1
  • Avoid setting arbitrary time limits for completing the taper; individualize based on patient response, as recommended by MMWR Recommendations and Reports 1